Product
CD19 CAR-T-cells
1 clinical trial
2 indications
Indication
B-cell Acute Lymphoblastic LeukemiaIndication
B-Cell LymphomaClinical trial
Pilot Study of CD19 CAR-T Cells Therapy for Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma in Children/Young AdultsStatus: Recruiting, Estimated PCD: 2023-06-01